May 24, 2000Novartis Consumer Health Inc.
Recalls Tavist-D(r) Tablets
NE (SafetyAlerts) - The Food and
Drug Administration (FDA) today reported that Novartis Consumer Health Inc. is conducting
a recall of Tavist-D(r) Tablets, (Clemastine Fumarate, USP 1.34 mg/ Phenylpropanolamine
HCL 75mg), 8 tablet units, because of low weight tablets.
The Tavist-D(r) Tablets were sold
over-the-counter and bear the Lot Number of 306295 EXP 3/02.
FDA stated in its report that 345,780
packages were distributed in Nebraska and Indiana.
This Class III recall
was initiated by the company, by letter on February 16, 2000. This is the first
public notice issued by the FDA. The report stated that the company had completed
required recall procedures.
Questions concerning this recall may
be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-346-0
Notice of this product warning was
sent via email to SafeMail
subscribers May 24, 2000.
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.